ESG Study: Companies & ESG - Transformation or just reporting?
12 July 2024
In line with the spirit of the time, it seems that the European Commission has set its sights on the pills industry. The legit one, that is. Moving away from its usual take on Article 102 TFEU cases, the Commission is not only targeting the pharma industry with cartel investigations, but also ramping up its antitrust scrutiny. It seems that the Covid honeymoon is over. So, can we expect an enforcement overdose in the coming months and years? Let's discuss.
